Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q16274732> ?p ?o }
Showing triples 1 to 24 of
24
with 100 triples per page.
- Q16274732 subject Q8760074.
- Q16274732 subject Q9536267.
- Q16274732 abstract "The drug combination bazedoxifene/conjugated estrogens (trade name Duavee in the US) is a medication approved by the Food and Drug Administration (FDA) for the treatment of menopause symptoms and postmenopausal osteoporosis. It is a fixed-dose combination drug containing the selective estrogen receptor modulator bazedoxifene and conjugated estrogens being marketed by the pharmaceutical company Pfizer.Duavee was approved by the US FDA on October 3, 2013, for use as a once-daily tablet. Pfizer expects the drug to become available in the first quarter of 2014.".
- Q16274732 atcPrefix "G03".
- Q16274732 atcSuffix "CC07".
- Q16274732 wikiPageWikiLink Q165328.
- Q16274732 wikiPageWikiLink Q177708.
- Q16274732 wikiPageWikiLink Q1779868.
- Q16274732 wikiPageWikiLink Q204711.
- Q16274732 wikiPageWikiLink Q206921.
- Q16274732 wikiPageWikiLink Q30.
- Q16274732 wikiPageWikiLink Q4875166.
- Q16274732 wikiPageWikiLink Q8760074.
- Q16274732 wikiPageWikiLink Q903917.
- Q16274732 wikiPageWikiLink Q9536267.
- Q16274732 atcPrefix "G03".
- Q16274732 atcSuffix "CC07".
- Q16274732 type ChemicalSubstance.
- Q16274732 type Drug.
- Q16274732 type ChemicalObject.
- Q16274732 type Thing.
- Q16274732 type Q8386.
- Q16274732 comment "The drug combination bazedoxifene/conjugated estrogens (trade name Duavee in the US) is a medication approved by the Food and Drug Administration (FDA) for the treatment of menopause symptoms and postmenopausal osteoporosis. It is a fixed-dose combination drug containing the selective estrogen receptor modulator bazedoxifene and conjugated estrogens being marketed by the pharmaceutical company Pfizer.Duavee was approved by the US FDA on October 3, 2013, for use as a once-daily tablet.".
- Q16274732 label "Bazedoxifene/conjugated estrogens".